Last reviewed · How we verify

NCT04541719

Patient Controlled Remifentanil Analgesia for Normal Labour

Withdrawn Phase 2 Last updated 9 September 2020
What this trial tests

Phase 2 trial testing Patient-controlled remifentanil analgesia in Labor Pain. Withdrawn.

Timeline
1 April 2017
Primary endpoint
1 May 2018
1 July 2018

Quick facts

Lead sponsorMansoura University
PhasePhase 2
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Start date1 April 2017
Primary completion1 May 2018
Estimated completion1 July 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

Adults 18 to 50, female only, with Labor Pain or Full Term Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patient controlled remifentanil analgesia might offer comparative overall patient satisfaction and improved quality of analgesia after normal labour with continuous epidural analgesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Labor Pain

Currently open trials in the same condition.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04541719.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing